文献速递中毒与环境急症

高剂量乙酰半胱氨酸在急性高危对乙酰氨基酚摄入中的评估

Assessment of high-dose acetylcysteine in acute high-risk paracetamol (acetaminophen) ingestion.
PubMed 文献 · Clin Toxicol (Phila) · 2024-07-25
一句话结论高危对乙酰氨基酚摄入后8小时内使用乙酰半胱氨酸(无论标准剂量或高剂量)肝毒性发生率低;超过8小时治疗者高剂量组肝毒性发生率反而更高,但肝衰竭率无差异。

该研究为单中心毒物中心回顾性研究,纳入2017年1月1日至2022年12月31日间急性对乙酰氨基酚摄入、初始血药浓度高于Rumack-Matthew列线图「300 mg/L」(1,985 μmol/L)线且接受静脉乙酰半胱氨酸治疗的190例病例,比较标准剂量与高剂量乙酰半胱氨酸的结局。结果显示,8小时内治疗者两组肝毒性无差异(OR 1.67,95%CI 0.067-42.3);超过8小时治疗者高剂量组肝毒性更常见(OR 3.39,95%CI 1.25-9.2),但肝衰竭几率相似(OR 2.78,95%CI 0.89-8.69)。88%的肝毒性患者就诊时转氨酶已升高,无患者死亡或接受肝移植。作者结论为及时使用乙酰半胱氨酸(无论剂量)可预防高危对乙酰氨基酚摄入的肝毒性。

要点

  • 高危对乙酰氨基酚摄入(初始浓度高于Rumack-Matthew列线图300 mg/L线)后8小时内静脉乙酰半胱氨酸治疗,标准剂量与高剂量组肝毒性无差异(OR 1.67,95%CI 0.067-42.3)。
  • 超过8小时才治疗者,高剂量乙酰半胱氨酸组肝毒性更常见(OR 3.39,95%CI 1.25-9.2),但肝衰竭几率相似(OR 2.78,95%CI 0.89-8.69)。
  • 88%的肝毒性患者就诊时转氨酶已升高,提示部分肝损伤在治疗前已存在。
  • 全部190例中无患者死亡或接受肝移植。
  • 作者结论:及时使用乙酰半胱氨酸(无论剂量)可预防高危对乙酰氨基酚摄入的肝毒性。

适用人群与场景

  • 单中心毒物中心2017年1月1日至2022年12月31日收录的急性对乙酰氨基酚摄入病例。
  • 纳入标准:接受静脉乙酰半胱氨酸治疗,且初始对乙酰氨基酚浓度高于Rumack-Matthew列线图「300 mg/L」(1,985 μmol/L)线。

诊断标准与关键阈值

  • 高危摄入定义:初始对乙酰氨基酚浓度高于Rumack-Matthew列线图「300 mg/L」(1,985 μmol/L)线。
  • 肝毒性定义:转氨酶活性 >1,000 U/L。

处置流程与药物剂量

  • 标准剂量乙酰半胱氨酸:300 mg/kg,21小时内分次给药(原文背景中描述为标准剂量)。

红旗征与不能漏的情况

  • 就诊时转氨酶已升高:88%的肝毒性患者就诊时转氨酶已升高。
  • 超过8小时才接受乙酰半胱氨酸治疗的高危患者:高剂量组肝毒性更常见(OR 3.39,95%CI 1.25-9.2)。

研究设计与关键结果

  • 研究类型:单中心毒物中心回顾性研究,纳入190例急性高危对乙酰氨基酚摄入病例。
  • 分组:56%接受标准剂量乙酰半胱氨酸,44%接受高剂量乙酰半胱氨酸。
  • 8小时内治疗者:两组肝毒性无差异(OR 1.67,95%CI 0.067-42.3)。
  • 超过8小时治疗者:高剂量组肝毒性更常见(OR 3.39,95%CI 1.25-9.2),但肝衰竭几率相似(OR 2.78,95%CI 0.89-8.69)。
  • 88%的肝毒性患者就诊时转氨酶已升高。
  • 无患者死亡或接受肝移植。

证据类型、等级与局限

  • 证据类型:回顾性毒物中心数据研究。
  • 局限:原文报告局限性为使用回顾性、自愿报告的毒物中心数据。

对床旁实践的改变

  • 作者结论:及时使用乙酰半胱氨酸(无论剂量)可预防高危对乙酰氨基酚摄入的肝毒性。
  • 超过8小时才治疗的高危患者中,高剂量乙酰半胱氨酸与肝毒性几率增加相关(OR 3.39,95%CI 1.25-9.2),但肝衰竭率无差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Prompt acetylcysteine treatment with standard doses (300 mg/kg over 21 h in divided doses) is almost universally effective in preventing hepatotoxicity after paracetamol (acetaminophen) overdose. However, hepatotoxicity is reported despite early treatment when paracetamol concentrations exceed 300 mg/L (1,985 μmol/L) at 4 h. Prior studies evaluating high-dose acetylcysteine to treat high-risk ingestions have shown mixed results. We compared outcomes in patients with high-risk ingestions receiving standard or high-dose acetylcysteine.

METHODS: Records from a single poison center were reviewed from 1 January 2017 to 31 December 2022. We included cases of acute paracetamol ingestion treated with intravenous acetylcysteine with an initial paracetamol concentration above the "300 mg/L" (1,985 μmol/L) line on the Rumack-Matthew nomogram. We compared standard and high-dose acetylcysteine groups by odds ratios and multivariable logistic regression. We defined hepatotoxicity as aminotransferase activity >1,000 U/L.

RESULTS: We included 190 cases. Fifty-six percent received standard-dose acetylcysteine while 44% received high-dose acetylcysteine. Treatment within 8 h yielded no difference in hepatotoxicity between groups (odds ratio 1.67, 95% CI 0.067-42.3). Among patients treated after 8 h, hepatoxicity was more common in the high-dose group (odds ratio 3.39, 95% CI 1.25-9.2) though odds of liver failure were similar (odds ratio 2.78, 95% CI 0.89-8.69). Eighty-eight percent of patients with hepatotoxicity had elevated aminotransferase activity at presentation. No patient died or received a liver transplant.

DISCUSSION: Rates of hepatotoxicity were low in patients treated within 8 h regardless of acetylcysteine dose. Unexpectedly, high-dose acetylcysteine treatment was associated with an increased odds of hepatoxicity in those treated after 8 h, but most had abnormal aminotransferase activities at presentation and there was no difference in rates of liver failure. Limitations include the use of retrospective, voluntarily reported poison center data.

CONCLUSIONS: Prompt treatment with acetylcysteine, regardless of dose, prevented hepatotoxicity in high-risk paracetamol ingestion.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Moss MJ, Hinchman B, Lambson JE, et al. Assessment of high-dose acetylcysteine in acute high-risk paracetamol (acetaminophen) ingestion. Clin Toxicol (Phila). 2024. PMID: 39051728. doi:10.1080/15563650.2024.2377268

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。